Abstract:Aims/hypothesis: This study aimed to investigate whether the effects of sleep duration interacted with the presence of diabetes. We specifically sought to examine the relationship between sleep duration and all-cause and cause-specific mortality in people with type 2 diabetes across sex, age at diagnosis, duration of diabetes and treatment type. Methods: The sample consisted of 273,029 adults, including 248,817 without diabetes and 24,212 with type 2 diabetes, who participated in the National Health Interview Survey from 2004 to 2013 and whose data were linked to a mortality database up to 31 December 2015. Sleep duration was measured using self-report, whereby participants were asked 'on average how long do you sleep each day (≤5, 6, 7, 8, 9 or ≥10 h/day)?' The relationship between sleep duration and mortality risk was investigated using Cox proportional hazards regression model, with adjustments for demographics, BMI, lifestyle behaviours and clinical variables. Results: Absolute mortality rate was higher in adults with diabetes and extremes of sleep duration (≤5 h/day, 215.0 per 10,000 person-years; ≥10 h/day, 363.5 per 10,000 person-years). There was a non-significant interaction between sleep duration and the presence of diabetes (p for interaction = 0.08). A J-shaped relationship existed between sleep duration and all-cause mortality risk in people with type 2 diabetes. Compared with the reference group (7 h/day), both shorter and longer sleep durations were associated with increased risk of all-cause mortality (≤5 h/day, HR 1.24 [95% CI 1.09, 1.40]; 6 h/day, HR 1.13 [1.01, 1.28]; 8 h/day, HR 1.17 [1.06, 1.30]; ≥10 h/day, HR 1.83 [1.61, 2.08]). Similar associations were also observed for mortality risk from CVD, cancer, kidney disease, Alzheimer's disease and chronic lower respiratory diseases. Longer sleep duration in those with a younger age at diabetes onset was associated with greater risks of all-cause and CVD mortality. Shorter sleep duration in individuals treated with both insulin and oral glucose-lowering medication was also associated with higher risks of all-cause and CVD mortality. Conclusions/interpretation: The associations between sleep duration and mortality risk may be different between diabetic and non-diabetic individuals. In people with type 2 diabetes, sleeping less or more than 7 h/day was associated with increased risk of all-cause and condition-specific mortality. The association was more prominent in those with a younger age at diabetes onset and receiving treatment with both oral glucose-lowering medication and insulin. This population may benefit from targeted sleep-related interventions to reduce the risks of adverse health outcomes. Graphical abstract.

[Relationship between both quality and duration of sleep and type 2 diabetes in middle-aged and elderly people in Shanghai].

A Novel Risk Score for Type 2 Diabetes Containing Sleep Duration: A 7-Year Prospective Cohort Study among Chinese Participants.

[The Relationship Between Sleep Quality and Glucose Level, Diabetic Complications in Elderly Type 2 Diabetes Mellitus].

Sleep Disturbances and Risk of Falls in an Old Chinese Population-Rugao Longevity and Ageing Study.

Depression and Sleep Duration Associated With Health-related Quality of Life in Individuals With Type 2 Diabetes: a Cross-sectional Study in China

Interaction of Sleep Quality and Sleep Duration on Glycemic Control in Patients with Type 2 Diabetes Mellitus.

[Association Between Sleep and Prevalence of Hypertension in Elderly Population].

Sleep Quality and Associated Factors in Elderly Patients with Type-2 Diabetes Mellitus

Abstract 10978: Sleep Duration and Risks of Cardiovascular Disease Onset and Mortality among Patients with Type 2 Diabetes

Sleep quality of patients with type 2 diabetes and its influencing factors

Restricted linear association between night sleep duration and diabetes risk in middle-aged and older adults: a 7-year follow-up analysis from the China health and retirement longitudinal study

Sleep Quality and Its Determinants Among Type 2 Diabetes Patients with Comorbid Metabolic Syndrome

Sleep quality and its associated factors among patients with type 2 diabetes mellitus in Hunan, China: a cross-sectional study

Clinical study on the relationship between sleep quality and glycemic control in patients with type 2 diabetes mellitus

[Relationship between sleep status and the risk of diabetes in adults].

Associations of Sleep Duration and Prediabetes Prevalence in a Middle‐aged and Elderly Chinese Population with Regard to Age and Hypertension: the China Health and Retirement Longitudinal Study Baseline Survey

Influencing Factors of Quality of Sleep in Patients with Type 2 Diabetes Mellitus

Association between sleep duration and mortality risk among adults with type 2 diabetes: a prospective cohort study

Association Between Sleep Disorder and Ambulatory Blood Pressure Rhythm in Patients with Type 2 Diabetes

ASSOCIATION BETWEEN CHRONIC DISEASE AND SLEEP QUALITY AND DURATION AMONG 18-59-YEAR-OLD ADULTS IN SOUTHERN CHINA

Association of Sleep Quality with Glycemic Variability Assessed by Flash Glucose Monitoring in Patients with Type 2 Diabetes